Skip to main content
. 2014 Aug 7;2014:727652. doi: 10.1155/2014/727652

Table 2.

Comparison of the characteristics between women with a normal OGTT and women with glucose intolerance/diabetes postpartum.

Normal
N = 94 (55.6%)
Glucose intolerance/diabetes
N = 75 (44.4%)
P value
Age mean years 31.8 ± 4.8 32.9 ± 4.6 0.141
BMI kg/m² at first prenatal visit (median) 24.1 (21.5–28.9) 27.8 (22.9–30.7) 0.019
% overweight at first prenatal visit 25.3 39.7 0.009
% obese at first prenatal visit 19.5 27.4 0.037
% excessive weight gain 31.3 23.0 0.241
% BME 24.5 45.3 0.004
% smoking before pregnancy 3.2 1.3 0.713
% first degree family member with T2DM 16.0 14.7 0.095
% history of GDM 5.3 17.3 0.016
% history of PCOS 2.1 2.7 0.905
% history of hypertension 3.2 5.3 0.569
% history of dyslipidaemia 3.2 1.3 0.261
% multipareous 26.6 44.0 0.028
% breastfeeding 77.7 73.0 0.536
% progestin-only oral contraceptive 62.5 67.8 0.527
Result GCT mg/dL (median) 159.0 (149.5–175.5) 168.0 (153.0–190.0) 0.007
Week at diagnosis of GDM (median) 27.0 (25.0–29.0) 26.0 (25.0–28.0) 0.030
% ≥4 values abnormal on 100 g OGTT 9.1 19.1 0.069
Median fasting 100 g OGTT mg/dL 88.0 (81.0–99.0) 94.5 (84.2–101.7) 0.006
Median 1 h 100 g OGTT mg/dL 188.0 (167.0–199.0) 191.5 (170.2–205.5) 0.312
Median 2 h 100 g OGTT mg/dL 168.0 (158.0–181.0) 175.0 (162.0–198.0) 0.003
Median 3 h 100 g OGTT mg/dL 144.0 (122.0–159.0) 151.5 (128.5–166.0) 0.058
HbA1c % (median) 5.3 (5.1–5.5) 5.4 (5.2–5.7) 0.443
% corticoid treatment 5.3 9.3 0.590
% insulin 24.5 33.8 0.203
Weeks start insulin (median) 30.0 (28.0–32.0) 29.0 (26.0–32.0) 0.367
% bolus-basal injections 17.4 52.0 0.032

BME: ethnic minority backgrounds; T2DM: type 2 diabetes; GDM: gestational diabetes; GCT: glucose challenge test: OGTT: oral glucose tolerance test; PCOS: polycystic ovary syndrome.